Resources
Aortic stenosis (AS) is one of the most common acquired heart defects in adults. Echocardiography is a primary diagnostic tool to assess the severity of this pathology. The assessment of
Is motivational interview a clinical tool?
Yes!
It's not a job interview, neither it's a coaching session. It's a technique to prompt a change in patient's lifestyle that physicians and nurses could/should
Ligence Heart analysis and reporting system for transthoracic echocardiography has been certified under MDR 2017/745.
The device is regulated as medical device class IIa under the framework of the European Commission.
The
A moment from a joint webinar "Digital Cardiology" organised by the Lithuanian Cardiology Society and Ligence.
The star guest Eugenio Picano delivered a presentation on what do clinicians want from AI
We are excited and proud to be working with leading minds in echocardiography to define the future of heart imaging. Ligence is participating in one of the largest echocardiography studies
The recent publication in Medscape, an online medical knowledge resource platform for medical professionals, suggests that echocardiography (2D transthoracic echocardiography) is the best practical prognostic measure for in-hospital patient mortality
Ligence has won the Innostars Awards hosted by the European Institute of Innovation and Technology. Ligence is a small startup company with a great idea and a heroic goal that
Ligence has been chosen to be displayed at the first in the world and first in Lithuania Startup Museum. The initiative is curated by Go Vilnius an agency for tourism
Heart ultrasound might be extremely important to patients tested positive for COVID-19. The disease itself shows very complex pathophysiological mechanisms and may cause a variety of illnesses. Therefore, the examination
There is so much hype on the AI in the social media that we thought there must be some clarification to it. We will help you explain why any new
Our CEO will participate in the programme with the intention to understand Canadian market better and broaden our network.